BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 24576773)

  • 1. [Lipoprotein(a) is associated to atherosclerosis in primary hypercholesterolemia].
    Bea AM; Mateo-Gallego R; Jarauta E; Villa-Pobo R; Calmarza P; Lamiquiz-Moneo I; Cenarro A; Civeira F
    Clin Investig Arterioscler; 2014; 26(4):176-83. PubMed ID: 24576773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carotid atherosclerosis and lipoprotein particle subclasses in familial hypercholesterolaemia and familial combined hyperlipidaemia.
    Jarauta E; Mateo-Gallego R; Gilabert R; Plana N; Junyent M; de Groot E; Cenarro A; Masana L; Ros E; Civeira F
    Nutr Metab Cardiovasc Dis; 2012 Jul; 22(7):591-7. PubMed ID: 21196102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
    Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
    Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein (a) levels are not associated with carotid plaques and carotid intima media thickness in statin-treated patients with familial hypercholesterolemia.
    Bos S; Duvekot MH; Touw-Blommesteijn AC; Verhoeven AJ; Mulder MT; Watts GF; Sijbrands EJ; Roeters van Lennep JE
    Atherosclerosis; 2015 Sep; 242(1):226-9. PubMed ID: 26222903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of carotid atherosclerosis in normocholesterolemic individuals with proven mutations in the low-density lipoprotein receptor or apolipoprotein B genes.
    Huijgen R; Vissers MN; Kindt I; Trip MD; de Groot E; Kastelein JJ; Hutten BA
    Circ Cardiovasc Genet; 2011 Aug; 4(4):413-7. PubMed ID: 21642693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease.
    Avellone G; Di Garbo V; Abruzzese G; Campisi D; De Simone R; Raneli G; Licata G
    Int Angiol; 2006 Mar; 25(1):26-34. PubMed ID: 16520721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.
    Alonso R; Andres E; Mata N; Fuentes-Jiménez F; Badimón L; López-Miranda J; Padró T; Muñiz O; Díaz-Díaz JL; Mauri M; Ordovás JM; Mata P;
    J Am Coll Cardiol; 2014 May; 63(19):1982-9. PubMed ID: 24632281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review.
    Narverud I; Retterstøl K; Iversen PO; Halvorsen B; Ueland T; Ulven SM; Ose L; Aukrust P; Veierød MB; Holven KB
    Atherosclerosis; 2014 Aug; 235(2):299-309. PubMed ID: 24908240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of HDL cholesterol on preclinical carotid atherosclerosis in familial hypercholesterolemia.
    Junyent M; Cofán M; Núñez I; Gilabert R; Zambón D; Ros E
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1107-13. PubMed ID: 16556855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipoprotein(a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients.
    Baldassarre D; Tremoli E; Franceschini G; Michelagnoli S; Sirtori CR
    Stroke; 1996 Jun; 27(6):1044-9. PubMed ID: 8650712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-density lipoprotein levels and not mutation status predict intima-media thickness in familial hypercholesterolemia.
    Fahed AC; Habib RH; Nemer GM; Azar ST; Andary RR; Arabi MT; Moubarak EM; Bitar FF; Haddad FF
    Ann Vasc Surg; 2014 Feb; 28(2):421-6. PubMed ID: 24120234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia.
    van Wissen S; Smilde TJ; Trip MD; de Boo T; Kastelein JJ; Stalenhoef AF
    Heart; 2003 Aug; 89(8):893-6. PubMed ID: 12860867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect.
    Carmena R; Lussier-Cacan S; Roy M; Minnich A; Lingenhel A; Kronenberg F; Davignon J
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):129-36. PubMed ID: 8548413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels.
    Ezhov MV; Safarova MS; Afanasieva OI; Pogorelova OA; Tripoten MI; Adamova IY; Konovalov GA; Balakhonova TV; Pokrovsky SN
    Atheroscler Suppl; 2015 May; 18():163-9. PubMed ID: 25936321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On-treatment C-reactive protein and HDL cholesterol levels in patients at intermediate cardiovascular risk: impact on carotid intima-media thickness.
    Pirro M; Vaudo G; Lupattelli G; Pasqualini L; Mannarino MR; Schillaci G; Alaeddin A; Paciullo F; Fallarino F; Bagaglia F; Mannarino E
    Life Sci; 2013 Sep; 93(8):338-43. PubMed ID: 23871987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial hypercholesterolemia and plasma Lp(a) levels: 2 cardiovascular risk factors].
    Real JT; Romero G; Priego MA; Chaves FJ; Ascaso JF; Carmena R
    An Med Interna; 1999 Feb; 16(2):69-72. PubMed ID: 10192997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carotid Plaques Correlates in Patients With Familial Hypercholesterolemia.
    Waluś-Miarka M; Czarnecka D; Wojciechowska W; Kloch-Badełek M; Kapusta M; Sanak M; Wójcik M; Małecki MT; Starzyk J; Idzior-Waluś B
    Angiology; 2016 May; 67(5):471-7. PubMed ID: 26198473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein receptor genotype and response to pravastatin in children with familial hypercholesterolemia: substudy of an intima-media thickness trial.
    Koeijvoets KC; Rodenburg J; Hutten BA; Wiegman A; Kastelein JJ; Sijbrands EJ
    Circulation; 2005 Nov; 112(20):3168-73. PubMed ID: 16286607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LDL-cholesterol goal achievement, cardiovascular disease, and attributed risk of Lp(a) in a large cohort of predominantly genetically verified familial hypercholesterolemia.
    Bogsrud MP; Græsdal A; Johansen D; Langslet G; Hovland A; Arnesen KE; Mundal LJ; Retterstøl K; Wium C; Holven KB
    J Clin Lipidol; 2019; 13(2):279-286. PubMed ID: 30910667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achilles tendon xanthomas are associated with the presence and burden of subclinical coronary atherosclerosis in heterozygous familial hypercholesterolemia: A pilot study.
    Mangili LC; Miname MH; Silva PRS; Bittencourt MS; Rocha VZ; Mangili OC; Salgado Filho W; Chacra AP; Jannes CE; Pereira AC; Santos RD
    Atherosclerosis; 2017 Aug; 263():393-397. PubMed ID: 28499609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.